Cutler Group LP Petros Pharmaceuticals, Inc. Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.68 - $1.49 $204 - $447	-300 Reduced 75.0%	100 $0
Q1 2022 Apr 14, 2022	BUY	$1.07 - $3.36 $428 - $1,344	400 New	400 $0
Q2 2021 Jul 19, 2021	SELL	$2.87 - $4.11 $975 - $1,397	-340 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$3.24 - $4.68 $1,101 - $1,591	340 New	340 $1,000

Ticker PTPI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,708,000
Market Cap $8.7M
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.